Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cg200745
2. N1-(3-(dimethylamino)propyl)-n8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide
1. Cg-200745
2. 936221-33-9
3. Cg200745
4. Cg-2
5. Hdcg-0745
6. 4i8mlm7l2h
7. Cg 2 (hdac Inhibitor)
8. J3.106.463e
9. (e)-n-(3-(dimethylamino)propyl)-n'-hydroxy-2-((1-naphthyloxy)methyl)-2-octenediamide
10. (e)-n1-(3-(dimethylamino)propyl)-n8-hydroxy-2-((naphthalen-1-yloxy)methyl)oct-2-enediamide
11. 2-octenediamide, N1-(3-(dimethylamino)propyl)-n8-hydroxy-2-((1-naphthalenyloxy)methyl)-, (2e)-
12. 3-[(1r,3s,5s)-3-({7-[(5-methyl-1h-pyrazol-3-yl)amino]-1,6-naphthyridin-5-yl}amino)8-azabicyclo[3.2.1]octan-8-yl]propanenitrile
13. (e)-n-[3-(dimethylamino)propyl]-n'-hydroxy-2-(naphthalen-1-yloxymethyl)oct-2-enediamide
14. Ivaltinostat [inn]
15. Unii-4i8mlm7l2h
16. Chembl4297366
17. Schembl16166645
18. Schembl16166647
19. Gtpl10055
20. Dtxsid801028069
21. Db12259
22. Hy-16138
23. Cs-0006157
24. Q27259620
25. (e)-n-(3-dimethylaminopropyl)-n'-hydroxy-2-(naphthalen-1-yloxymethyl)oct-2-enediamide
| Molecular Weight | 427.5 g/mol |
|---|---|
| Molecular Formula | C24H33N3O4 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 13 |
| Exact Mass | 427.24710654 g/mol |
| Monoisotopic Mass | 427.24710654 g/mol |
| Topological Polar Surface Area | 90.9 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 579 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
93
PharmaCompass offers a list of CG200745 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CG200745 manufacturer or CG200745 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CG200745 manufacturer or CG200745 supplier.
PharmaCompass also assists you with knowing the CG200745 API Price utilized in the formulation of products. CG200745 API Price is not always fixed or binding as the CG200745 Price is obtained through a variety of data sources. The CG200745 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CG200745 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CG200745, including repackagers and relabelers. The FDA regulates CG200745 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CG200745 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CG200745 supplier is an individual or a company that provides CG200745 active pharmaceutical ingredient (API) or CG200745 finished formulations upon request. The CG200745 suppliers may include CG200745 API manufacturers, exporters, distributors and traders.
CG200745 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CG200745 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CG200745 GMP manufacturer or CG200745 GMP API supplier for your needs.
A CG200745 CoA (Certificate of Analysis) is a formal document that attests to CG200745's compliance with CG200745 specifications and serves as a tool for batch-level quality control.
CG200745 CoA mostly includes findings from lab analyses of a specific batch. For each CG200745 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CG200745 may be tested according to a variety of international standards, such as European Pharmacopoeia (CG200745 EP), CG200745 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CG200745 USP).
